Executives at Bausch Health Cos Inc are shaking up the company’s team of advisers as part of the latest in a years-long ...

LAVAL, QC / ACCESS Newswire / January 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2024 financial results after market close on Wednesday, ...

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better ...

Bausch + Lomb moved to bolster the eye-care company's pipeline of clinical-stage offerings with the acquisition of Whitecap Biosciences, a firm developing two therapies for potential use in glaucoma ...

LAVAL, QC - Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a pharmaceutical company with a market capitalization of $2.81 ...

Shares of Bausch Health Companies Inc. (NYSE:BHC – Get Free Report) have been given a consensus rating of “Hold” by the seven ratings firms that are presently covering the stock, Marketbeat Ratings ...

Companies and Salix Pharmaceuticals acknowledged that the Centers for Medicare and Medicaid Services has selected XIFAXAN ...

In a report released today, Patrick Wood from Morgan Stanley maintained a Hold rating on Bausch + Lomb Corporation (BLCO – Research Report), ...

InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration ...

Bausch + Lomb Corp. announced on Monday that an affiliate has acquired Whitecap Biosciences, LLC, which is currently ...

The acquisition strengthens Bausch + Lomb’s expanding clinical ... About Whitecap Biosciences, LLC Whitecap Biosciences is a pharmaceutical company founded in 2015 and focused on novel therapies ...

“By joining a global leader like Bausch + Lomb, we hope Whitecap’s assets will be developed into effective treatments that improve visual outcomes for patients.” Whitecap Biosciences is a ...